RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.195
-0.025 (-2.05%)
Aug 14, 2025, 1:58 PM - Market open
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $43.70 million as of August 14, 2025. Its market cap has increased by 42.55% in one year.
Market Cap
43.70M
Enterprise Value
30.32M
1-Year Change
42.55%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $43.70M, a decrease of -36.33%. That is a compound annual growth rate of -10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 44.62M | 44.11% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |